Blood And Blood Components Market Report 2026

Blood And Blood Components Market Overview

• Blood And Blood Components market size has reached to $43 billion in 2025 • Expected to grow to $55.16 billion in 2030 at a compound annual growth rate (CAGR) of 5% • Growth Driver: Expanding Demand For Blood And Components In Response To Prevalent Bleeding Disorders • Market Trend: Advanced Precision Blood Typing Technology • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Blood And Blood Components Market?

Blood and Blood Components refers to the different parts of blood, such as red blood cells, white blood cells, platelets, and plasma, separated for medical use. These components are used to treat various conditions like anemia, clotting disorders, and immune deficiencies. Each component is transfused based on the patient's specific needs for recovery. The main types of products in blood and blood components are whole blood and blood components. Human blood from a typical blood donation is known as whole blood. It is utilized in the treatment of excessive bleeding, exchange transfusions, and self-donation of blood. The different blood components include red blood cells, platelets, plasma, and white blood cells and are used in anemia, trauma and surgery, cancer treatment, and bleeding disorders. The several end-users involved are hospitals, ambulatory surgical centers, and others.

What Is The Blood And Blood Components Market Growth Forecast?

The blood and blood components market size is expected to see steady growth in the next few years. It will grow to $55.16 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing demand for personalized transfusion medicine, rising investments in advanced storage technologies, expansion of oncology and hematology treatments, growing adoption of pathogen reduction technologies, increasing focus on minimizing blood wastage. Major trends in the forecast period include increasing demand for component-specific transfusions, rising adoption of automated blood component separation, growing use of platelet and plasma therapies, expansion of advanced blood storage solutions, enhanced focus on inventory optimization.

Global Blood And Blood Components Market Segmentation

1) By Product: Whole Blood, Blood Components 2) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users 3) By Application: Anemia, Trauma and Surgery, Cancer Treatment, Bleeding Disorders Subsegments: 1) By Whole Blood: Donor Whole Blood, Autologous Whole Blood 2) By Blood Components: Red Blood Cells (RBCs), Platelets, Plasma, White Blood Cells (WBCs)

What Is The Driver Of The Blood And Blood Components Market?

The growing prevalence of bleeding disorders is expected to propel the growth of the blood and blood components market going forward. Bleeding disorders including hemophilia are a group of medical conditions characterized by impaired blood clotting, which can lead to excessive or prolonged bleeding, even from minor injuries or spontaneously. Blood and blood components are crucial for the treatment of blood disorders, as they provide essential components such as red blood cells, platelets, and clotting factors, which can be transfused to replace or supplement the deficient or dysfunctional elements in patients, improving their clotting ability and overall health. For instance, in July 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, hemophilia A occurs in approximately one in 5,000 male births in the United States, and about 400 babies are born with hemophilia A each year in the United States. Additionally, the current number of males with hemophilia living in the United States is estimated to be between 30,000 and 33,000. Therefore, the growing prevalence of bleeding disorders is driving the growth of the blood and blood components industry.

Key Players In The Global Blood And Blood Components Market

Major companies operating in the blood and blood components market are American Red Cross, The Japanese Red Cross Society, Canadian Blood Services, Australian Red Cross, Vitalant, SANQUIN BLOOD SUPPLY FOUNDATION, New York Blood Center, Blood Bank of Alaska, Blood Centers of America, Xinjiang Deyuan Bioengineering, Harbin Pacific Biopharmaceutical, Southern Shuanglin Bio-Pharmacy, Beijing Tiantan Biological Products, Shanghai RAAS Blood Products, China Biologic Products, Hualan Biological Engineering, Biotest AG, Lorne Laboratories UK, LMB Germany, Bio Products Laboratory Ltd, Kedrion Biopharma, Hemanext Inc., Cellphire Inc., CSL Behring, Octapharma Canada Inc., Grifols

Global Blood And Blood Components Market Trends and Insights

Major companies operating in the blood and blood component market are focusing on developing innovative technology, such as an innovative precision blood typing process, to prevent blood transfusion complications during the procedure. Precision blood typing is a proprietary blood typing process that utilizes advanced techniques and technologies to precisely determine an individual's blood type, including the specific blood group and subgroup, to ensure the accurate and safe transfusion of blood or blood products. For instance, in April 2023, San Diego Blood Bank, a US-based blood bank, launched its precision blood initiative, which aims to improve the standard of care for blood transfusion patients by scaling the precision blood typing process. The program aims to positively change and save lives by improving the standard of care for blood transfusion patients.

What Are Latest Mergers And Acquisitions In The Blood And Blood Components Market?

In December 2024, GC Biopharma Corp., a South Korea–based biopharmaceutical company, acquired ABO Holdings, Inc., for an undisclosed amount. Through this acquisition, GC Biopharma strengthens its vertically integrated plasma-supply capabilities and supports the expansion of its immunoglobulin business in the United States. ABO Holdings, Inc. is a US-based operator of plasma collection centers that supply source plasma, a critical blood component used in plasma-derived therapies.

Regional Outlook

North America was the largest region in the blood and blood components market in 2025. Western Europe was the second largest region in the global blood and blood components market analysis. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Blood And Blood Components Market?

The blood and blood components market consists of sales of red cells, platelets, plasms, cryoprecipitated AHF, and granulocytes. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Blood And Blood Components Market Report 2026?

The blood and blood components market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the blood and blood components industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.